Gilead’s Trodelvy Wins In TROPiCS-02, But Commercial Headwinds Remain

 
• By Alaric DeArment
  
Gilead announced an OS benefit in the Phase III TROPiCS-02 trial, but Trodelvy faces commercial headwinds • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Strategy

More from Business